SCHEDULE 13G
Statement of Beneficial Ownership
Stoke Therapeutics, Inc. Filed Acc 0002052113-25-000328
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
- 2026-11-16 SCHEDULE 13G/A · RTW Investments, LP 9.9%
- 2026-11-16 SCHEDULE 13G/A · Baker Bros. Advisors LP 4.7%
- 2026-11-16 SCHEDULE 13G/A · Wellington Management Group LLP 7.3%
- 2026-11-13 SCHEDULE 13G/A · Morgan Stanley 4.9%
- 2026-08-12 SCHEDULE 13G/A · The Toronto-Dominion Bank 4.9%
- 2026-05-15 SCHEDULE 13G/A · The Toronto-Dominion Bank 5.4%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…